Back to Course

2025 PACUPrep BCCCP Preparatory Course

0% Complete
0/0 Steps
  1. Pulmonary

    ARDS
    4 Topics
    |
    1 Quiz
  2. Asthma Exacerbation
    4 Topics
    |
    1 Quiz
  3. COPD Exacerbation
    4 Topics
    |
    1 Quiz
  4. Cystic Fibrosis
    6 Topics
    |
    1 Quiz
  5. Drug-Induced Pulmonary Diseases
    3 Topics
    |
    1 Quiz
  6. Mechanical Ventilation Pharmacotherapy
    5 Topics
    |
    1 Quiz
  7. Pleural Disorders
    5 Topics
    |
    1 Quiz
  8. Pulmonary Hypertension (Acute and Chronic severe pulmonary hypertension)
    5 Topics
    |
    1 Quiz
  9. Cardiology
    Acute Coronary Syndromes
    6 Topics
    |
    1 Quiz
  10. Atrial Fibrillation and Flutter
    6 Topics
    |
    1 Quiz
  11. Cardiogenic Shock
    4 Topics
    |
    1 Quiz
  12. Heart Failure
    7 Topics
    |
    1 Quiz
  13. Hypertensive Crises
    5 Topics
    |
    1 Quiz
  14. Ventricular Arrhythmias and Sudden Cardiac Death Prevention
    5 Topics
    |
    1 Quiz
  15. NEPHROLOGY
    Acute Kidney Injury (AKI)
    5 Topics
    |
    1 Quiz
  16. Contrast‐Induced Nephropathy
    5 Topics
    |
    1 Quiz
  17. Drug‐Induced Kidney Diseases
    5 Topics
    |
    1 Quiz
  18. Rhabdomyolysis
    5 Topics
    |
    1 Quiz
  19. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
    5 Topics
    |
    1 Quiz
  20. Renal Replacement Therapies (RRT)
    5 Topics
    |
    1 Quiz
  21. Neurology
    Status Epilepticus
    5 Topics
    |
    1 Quiz
  22. Acute Ischemic Stroke
    5 Topics
    |
    1 Quiz
  23. Subarachnoid Hemorrhage
    5 Topics
    |
    1 Quiz
  24. Spontaneous Intracerebral Hemorrhage
    5 Topics
    |
    1 Quiz
  25. Neuromonitoring Techniques
    5 Topics
    |
    1 Quiz
  26. Gastroenterology
    Acute Upper Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  27. Acute Lower Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  28. Acute Pancreatitis
    5 Topics
    |
    1 Quiz
  29. Enterocutaneous and Enteroatmospheric Fistulas
    5 Topics
    |
    1 Quiz
  30. Ileus and Acute Intestinal Pseudo-obstruction
    5 Topics
    |
    1 Quiz
  31. Abdominal Compartment Syndrome
    5 Topics
    |
    1 Quiz
  32. Hepatology
    Acute Liver Failure
    5 Topics
    |
    1 Quiz
  33. Portal Hypertension & Variceal Hemorrhage
    5 Topics
    |
    1 Quiz
  34. Hepatic Encephalopathy
    5 Topics
    |
    1 Quiz
  35. Ascites & Spontaneous Bacterial Peritonitis
    5 Topics
    |
    1 Quiz
  36. Hepatorenal Syndrome
    5 Topics
    |
    1 Quiz
  37. Drug-Induced Liver Injury
    5 Topics
    |
    1 Quiz
  38. Dermatology
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    5 Topics
    |
    1 Quiz
  39. Erythema multiforme
    5 Topics
    |
    1 Quiz
  40. Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS)
    5 Topics
    |
    1 Quiz
  41. Immunology
    Transplant Immunology & Acute Rejection
    5 Topics
    |
    1 Quiz
  42. Solid Organ & Hematopoietic Transplant Pharmacotherapy
    5 Topics
    |
    1 Quiz
  43. Graft-Versus-Host Disease (GVHD)
    5 Topics
    |
    1 Quiz
  44. Hypersensitivity Reactions & Desensitization
    5 Topics
    |
    1 Quiz
  45. Biologic Immunotherapies & Cytokine Release Syndrome
    5 Topics
    |
    1 Quiz
  46. Endocrinology
    Relative Adrenal Insufficiency and Stress-Dose Steroid Therapy
    5 Topics
    |
    1 Quiz
  47. Hyperglycemic Crisis (DKA & HHS)
    5 Topics
    |
    1 Quiz
  48. Glycemic Control in the ICU
    5 Topics
    |
    1 Quiz
  49. Thyroid Emergencies: Thyroid Storm & Myxedema Coma
    5 Topics
    |
    1 Quiz
  50. Hematology
    Acute Venous Thromboembolism
    5 Topics
    |
    1 Quiz
  51. Drug-Induced Thrombocytopenia
    5 Topics
    |
    1 Quiz
  52. Anemia of Critical Illness
    5 Topics
    |
    1 Quiz
  53. Drug-Induced Hematologic Disorders
    5 Topics
    |
    1 Quiz
  54. Sickle Cell Crisis in the ICU
    5 Topics
    |
    1 Quiz
  55. Methemoglobinemia & Dyshemoglobinemias
    5 Topics
    |
    1 Quiz
  56. Toxicology
    Toxidrome Recognition and Initial Management
    5 Topics
    |
    1 Quiz
  57. Management of Acute Overdoses – Non-Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  58. Management of Acute Overdoses – Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  59. Toxic Alcohols and Small-Molecule Poisons
    5 Topics
    |
    1 Quiz
  60. Antidotes and Gastrointestinal Decontamination
    5 Topics
    |
    1 Quiz
  61. Extracorporeal Removal Techniques
    5 Topics
    |
    1 Quiz
  62. Withdrawal Syndromes in the ICU
    5 Topics
    |
    1 Quiz
  63. Infectious Diseases
    Sepsis and Septic Shock
    5 Topics
    |
    1 Quiz
  64. Pneumonia (CAP, HAP, VAP)
    5 Topics
    |
    1 Quiz
  65. Endocarditis
    5 Topics
    |
    1 Quiz
  66. CNS Infections
    5 Topics
    |
    1 Quiz
  67. Complicated Intra-abdominal Infections
    5 Topics
    |
    1 Quiz
  68. Antibiotic Stewardship & PK/PD
    5 Topics
    |
    1 Quiz
  69. Clostridioides difficile Infection
    5 Topics
    |
    1 Quiz
  70. Febrile Neutropenia & Immunocompromised Hosts
    5 Topics
    |
    1 Quiz
  71. Skin & Soft-Tissue Infections / Acute Osteomyelitis
    5 Topics
    |
    1 Quiz
  72. Urinary Tract and Catheter-related Infections
    5 Topics
    |
    1 Quiz
  73. Pandemic & Emerging Viral Infections
    5 Topics
    |
    1 Quiz
  74. Supportive Care (Pain, Agitation, Delirium, Immobility, Sleep)
    Pain Assessment and Analgesic Management
    5 Topics
    |
    1 Quiz
  75. Sedation and Agitation Management
    5 Topics
    |
    1 Quiz
  76. Delirium Prevention and Treatment
    5 Topics
    |
    1 Quiz
  77. Sleep Disturbance Management
    5 Topics
    |
    1 Quiz
  78. Immobility and Early Mobilization
    5 Topics
    |
    1 Quiz
  79. Oncologic Emergencies
    5 Topics
    |
    1 Quiz
  80. End-of-Life Care & Palliative Care
    Goals of Care & Advance Care Planning
    5 Topics
    |
    1 Quiz
  81. Pain Management & Opioid Therapy
    5 Topics
    |
    1 Quiz
  82. Dyspnea & Respiratory Symptom Management
    5 Topics
    |
    1 Quiz
  83. Sedation & Palliative Sedation
    5 Topics
    |
    1 Quiz
  84. Delirium Agitation & Anxiety
    5 Topics
    |
    1 Quiz
  85. Nausea, Vomiting & Gastrointestinal Symptoms
    5 Topics
    |
    1 Quiz
  86. Management of Secretions (Death Rattle)
    5 Topics
    |
    1 Quiz
  87. Fluids, Electrolytes, and Nutrition Management
    Intravenous Fluid Therapy and Resuscitation
    5 Topics
    |
    1 Quiz
  88. Acid–Base Disorders
    5 Topics
    |
    1 Quiz
  89. Sodium Homeostasis and Dysnatremias
    5 Topics
    |
    1 Quiz
  90. Potassium Disorders
    5 Topics
    |
    1 Quiz
  91. Calcium and Magnesium Abnormalities
    5 Topics
    |
    1 Quiz
  92. Phosphate and Trace Electrolyte Management
    5 Topics
    |
    1 Quiz
  93. Enteral Nutrition Support
    5 Topics
    |
    1 Quiz
  94. Parenteral Nutrition Support
    5 Topics
    |
    1 Quiz
  95. Refeeding Syndrome and Specialized Nutrition
    5 Topics
    |
    1 Quiz
  96. Trauma and Burns
    Initial Resuscitation and Fluid Management in Trauma
    5 Topics
    |
    1 Quiz
  97. Hemorrhagic Shock, Massive Transfusion, and Trauma‐Induced Coagulopathy
    5 Topics
    |
    1 Quiz
  98. Burns Pharmacotherapy
    5 Topics
    |
    1 Quiz
  99. Burn Wound Care
    5 Topics
    |
    1 Quiz
  100. Open Fracture Antibiotics
    5 Topics
    |
    1 Quiz

Participants 432

  • Allison Clemens
  • April
  • ababaabhay
  • achoi2392
  • adhoward1
Show more
Lesson 84, Topic 5
In Progress

Recovery, De-Escalation, and Transition of Care in ICU Delirium, Agitation & Anxiety

Lesson Progress
0% Complete
Recovery and De-Escalation in ICU Delirium, Agitation & Anxiety

Recovery, De-Escalation, and Transition of Care in ICU Delirium, Agitation & Anxiety

Objectives Icon A checkmark inside a circle, symbolizing achieved goals.

Learning Objective

Develop a plan to facilitate patient recovery, mitigate long-term complications, and ensure a safe transition of care.

1. Weaning and De-Escalation Protocols

As neurologic function improves, structured daily sedation interruption (SAT) and spontaneous breathing trial (SBT) protocols reduce delirium duration and ventilator days while maintaining safety.

Eligibility and Procedure for SAT/SBT

  • Eligibility for SATs: Hemodynamic stability (no escalating vasopressors in past 2 hours), FiO₂ ≤ 60% and PEEP ≤ 10 cm H₂O, and not receiving neuromuscular blockers.
  • SAT Procedure: Stop all continuous sedatives. Assess Richmond Agitation-Sedation Scale (RASS) every 10–15 minutes for up to 60 minutes. If the SAT is successful (RASS ≥ –2 and no adverse events), resume sedation at 50% of the prior dose and titrate to a target RASS of –1 to 0.
  • SAT + SBT Pairing: Immediately follow a successful SAT with an SBT (using a T-piece or low pressure support ventilation). Failure criteria include respiratory rate > 35 breaths/min, SpO₂ < 88%, heart rate > 140 bpm, or signs of respiratory distress. If failed, revert to prior ventilator settings and plan to retry in 24 hours.
  • Safety Stop Criteria: Immediately stop the trial and reinstate sedation for SpO₂ < 88%, mean arterial pressure (MAP) < 60 mmHg, or RASS > +2. Re-evaluate for another trial every 4 hours.
Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Clinical Pearls
  • Protocolized pairing of SAT and SBT has been shown to shorten total sedation exposure, reduce ventilator days, and decrease ICU length of stay.
  • Conducting these trials during multidisciplinary rounds ensures consistent execution, clear communication, and accurate documentation among the care team.

2. IV-to-Enteral Conversion Strategies

Transitioning from intravenous (IV) sedatives and analgesics to enteral formulations is a key step that reduces line-related complications and facilitates step-down care. However, clinicians must be aware that absorption can be unpredictable in critically ill patients.

Pharmacokinetic Considerations

Critical illness significantly alters drug absorption due to several factors:

  • Splanchnic Hypoperfusion: Reduced blood flow to the gut can impair drug uptake.
  • Mucosal Edema and Ileus: Swelling of the gut lining and delayed gastric emptying can lead to erratic absorption.
  • Mitigation Strategies: Using post-pyloric feeding tubes and administering prokinetic agents (e.g., metoclopramide 10 mg q6h) may improve drug delivery and absorption.

Dose Equivalency & Cross-Titration

Approximate IV-to-Enteral Dose Conversions for Sedatives
IV Agent IV Rate PO Equivalent Bioavailability Titration Guidance
Lorazepam 1 mg IV q6h 2.5 mg PO q6h (Ratio ~1:2.5) ~90% Increase by 0.5–1 mg every 24h
Midazolam 1 mg/hr infusion 7.5 mg PO q8h (Ratio ~1:7.5) 40–50% Increase by 2.5 mg every 8–12h
Hydroxyzine 50 mg PO q12h Adjust for hepatic function
Melatonin 3–10 mg PO qhs Increase by 1–3 mg nightly

Cross-Titration Plan

  1. Start the enteral agent at 25–50% of the target dose while the IV infusion is still running.
  2. Over the next 12–24 hours, gradually decrease the IV infusion rate by 10–20% per interval as the enteral dose is uptitrated.
  3. Continuously monitor RASS (target –2 to 0) and observe for signs of withdrawal, such as agitation, hypertension, or tachycardia.
Pitfall Icon A chat bubble with a question mark, indicating a potential pitfall or point of caution. Common Pitfalls
  • Tapering the IV medication too rapidly in a patient with poor enteral absorption can precipitate acute withdrawal.
  • Failing to check enteral tube position and measure gastric residuals before administering doses can lead to therapeutic failure or aspiration.

3. Mitigation of Post-ICU Syndrome (PICS)

Post-ICU Syndrome (PICS) is a constellation of physical, cognitive, and psychological impairments that persist long after discharge. Implementing the ABCDEF bundle and promoting early rehabilitation are the most effective strategies to reduce its incidence and severity.

ABCDEF Bundle for ICU Care A hexagonal diagram illustrating the six components of the ABCDEF bundle: A for Assess Pain, B for Both SAT/SBT, C for Choice of Sedation, D for Delirium Monitoring, E for Early Mobility, and F for Family Engagement. AAssess, Prevent& Manage Pain BBoth SAT& SBT CChoice ofAnalgesia/Sedation DDelirium: Assess,Prevent & Manage EEarly Mobility& Exercise FFamily Engagement& Empowerment
Figure 1: The ABCDEF Bundle. A multicomponent, evidence-based organizational approach to improve communication among ICU team members, standardize care processes, and reduce long-term consequences of critical illness.

Early Mobilization & Cognitive Rehab

  • Initiate passive range-of-motion exercises on day 1 of ICU admission.
  • Progress as tolerated to in-bed cycling, sitting at the edge of the bed, and ambulation when feasible.
  • Provide cognitive stimulation through frequent reorientation, memory tasks, and placing clocks and calendars at the bedside.

Psychological Screening & Support

  • Use validated screening tools like the Hospital Anxiety and Depression Scale (HADS) or encourage ICU diaries to identify patients at high risk for PTSD.
  • Coordinate early referrals to psychology or psychiatry for high-risk patients before discharge.

4. Medication Reconciliation & Discharge Counseling

A thorough review of ICU and pre-admission medications is critical to identify and deprescribe deliriogenic agents. Clear patient and caregiver education is essential for ensuring a safe transition of care.

A. Deprescribing Deliriogenic Medications

  • Identify Culprits: Systematically review the medication list for agents introduced in the ICU, particularly benzodiazepines, anticholinergics, and long-acting opioids.
  • Develop a Taper Plan: For agents like benzodiazepines, create a structured taper schedule (e.g., 10–20% dose reduction daily) to prevent withdrawal.

B. Discharge Medication List & Education Tools

  • Reconcile Lists: Carefully reconcile the patient’s home medication list with the ICU list. Reinstate baseline neuropsychiatric drugs as soon as it is safe to do so.
  • Provide Clear Instructions: Create a patient-friendly medication schedule that includes drug names, simple indications, and dosing times.

C. Key Counseling Topics

  • Sleep Hygiene: Advise on maintaining a consistent bedtime, minimizing nighttime stimuli, and avoiding daytime napping.
  • Pain Control: Encourage the use of non-opioid analgesics like acetaminophen or NSAIDs as first-line options.
  • Warning Signs: Educate the patient and family on recognizing signs of confusion, agitation, or withdrawal symptoms and when to seek medical help.
  • Follow-Up: Arrange a follow-up appointment within 7 days specifically to reassess cognitive status and functional ability.
Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Clinical Pearl

Integrating standardized discharge summary templates into the electronic health record (EHR) that specifically prompt for delirium history and medication reconciliation can significantly reduce medication errors and hospital readmissions.

5. Interdisciplinary Handoff & Long-Term Planning

Structured communication between care teams and coordinated referrals to outpatient services are vital for optimizing a patient’s recovery trajectory and ensuring continuity of care after ICU discharge.

A. Handoff Templates

  • Utilize a standardized handoff tool like SBAR (Situation, Background, Assessment, Recommendation) to convey critical information, including delirium history, total sedation exposure, SAT/SBT performance, and overall PICS risk.

B. Team Coordination and Referrals

  • Engage palliative care for goals-of-care discussions if cognitive impairment is prolonged or recovery is uncertain.
  • Establish clear referral triggers, such as persistent delirium lasting more than one month, which should prompt a neurology consult for formal neuropsychological testing.
  • Arrange for physical, occupational, and speech therapy outpatient services prior to the patient’s discharge.

C. Follow-Up & Quality Metrics

  • Schedule a follow-up appointment at a dedicated PICS clinic or with the primary care provider within two weeks of discharge.
  • Track key quality metrics, including readmission rates for delirium or withdrawal, patient-reported outcome measures (PROMs), and unit-wide adherence to the ABCDEF bundle.
Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Key Pearls
  • Early enrollment in a comprehensive rehabilitation program has been shown to reduce 6-month functional deficits and hospital readmissions.
  • Using quality dashboards to display bundle adherence and patient outcomes can drive multidisciplinary accountability and continuous process improvement.

References

  1. Devlin JW, Skrobik Y, Gélinas C, et al. Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult ICU patients. Crit Care Med. 2018;46(9):e825-e873.
  2. Pun BT, Balas MC, Barnes-Daly MA, et al. Effectiveness of bundle interventions on ICU delirium. Crit Care Med. 2021;49(2):e123-e134.
  3. Bellani G, Foti G, L’Acqua C, et al. Enteral vs intravenous ICU sedation management: a randomized controlled trial. Crit Care. 2013;17(2):R67.
  4. Bellani G, Laffey JG, Pham T, et al. Enteral versus intravenous approach for sedation of critically ill patients: a multicenter randomized trial. Crit Care. 2019;23(1):8.
  5. Children’s Hospital of Philadelphia Clinical Pathways Team. Sedation/Analgesia for Mechanically Ventilated PICU Patients Clinical Pathway. 2025.
  6. Ankravs MJ, McKenzie CA, Kenes MT. Precision-based approaches to delirium in critical illness: A narrative review. Pharmacotherapy. 2023;43(11):1139-1153.
  7. Roberts J. Weaning strategies in the ICU for ventilated patients. Respiratory Therapy. 2023.
  8. Hick JL, Hanfling D, Wynia MK, Pavia AT. Crisis standards of care: de-escalation of care. ASPR TRACIE. 2020.